NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...
A renowned virologist and former vice-chancellor of Redeemer’s University, Prof. Oyewale Tomori, has warned that Lassa fever ...
The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback